Navigation Links
BIA Publishes White Paper: ISO 9000 Role in Document Review, Emphasizes 'Quality Equals Defensibility'

NEW YORK, Oct. 2 /PRNewswire/ -- Business Intelligence Associates, Inc. (BIA), an information management industry leader, today released "The Role of ISO 9000 in Document Review". This white paper highlights BIA's recent ISO 9001:2008 certification for its Document Review Services' Quality Management System.

BIA's white paper identifies difficulties and solutions in developing a document review Quality Management System (QMS), where human-based services depend on the professional judgment of attorney reviewers. Part of its solution is its ISO 9000 certification, which assures clients of operational ISO QMS standards.

"BIA's Document Review Services are independent of any single review tool or platform," states Adam Feinberg, BIA's Director of Quality Assurance. "With our ISO 9001:2008 certified process-based approach, we reduce overall review project time with error-checking methods - thereby controlling client costs - regardless of the review platform used."

Feinberg adds, "BIA spent over a year ensuring that there is a documented, process-based approach provided to all Document Review Services clients. The use of existing ISO 9000 Quality standards means that BIA's document review services can be defended to the courts whenever necessary. BIA's assertion - that quality equals defensibility - is critical to defensible solutions."

BIA's white paper highlights several pertinent items, including BIA's accuracy hybrid-database that identifies patterns and errors; "process-driven" document reviews and outcomes; and issues facing "agencies'" hiring of part-time attorneys.

BIA's white paper may be downloaded:

About BIA

Since 2002, BIA has been dedicated to the development and implementation of defensible, technology-driven solutions that reduce the costs and risks associated with the management and analysis of digital evidence and critical corporate data. BIA offers a wide range of services including Preservation & Collection, Processing & Analytics, Digital Investigations, Commercial Fraud Investigations & Analysis, Electronic Policy Consulting, Audit/Certification Services, HR Data Related Policy, Disaster Recovery, and Legal Document Review. Clients include Fortune 100, Global 2000 and Legal 500 companies, and government agencies. Headquartered in New York City, BIA has additional offices in San Francisco, Washington, DC, and a central processing center in Southwest Michigan. BIA maintains digital evidence response units throughout the United States, Europe, Asia, and the Middle East. BIA's unique and positive workplace culture promotes diversity and celebrates the professional skills of each individual.

For more information about BIA, please visit

For additional information, contact Erin K. Smith: 888.338.4242 or

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Adam Hurwitz

Alon Israely

Brian Schrader

Maurice Bortz

SOURCE Business Intelligence Associates, Inc.

SOURCE Business Intelligence Associates, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. United States Patent and Trademark Office Publishes Stemedicas Patent Application for the Treatment of Diabetic Retinopathy
2. The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide
3. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
4. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
5. Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinsons Disease
6. New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
7. Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
8. American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation
9. New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
10. Journal of the American Dental Association Publishes Key Clinical Data for the Use of OraVerse(TM) a Local Anesthetic Reversal Agent
11. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):